Cancer Patients on Medicaid Fair Poorly

Published Online: June 05, 2014

Medicaid patients appear to receive worse cancer care than people who can afford private insurance, a trio of new studies says.

Those covered by Medicaid, the federal health plan for low-income people, are less likely to have their cancer caught at an earlier, more treatable phase. Medicaid patients also are more likely to die from cancer than people with private insurance, researchers found. Many factors likely contribute to this, including the fact that Medicaid patients often aren't experienced in navigating the health care system, said Dr. Jyoti Patel, an oncologist at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University in Chicago.

"Research has shown that we can screen more patients, but that they get dropped along the way to treatment. We don't give them full access into curative therapy," said Patel, who's also a spokeswoman for the American Society of Clinical Oncology. "We need to do a better job to make sure that people who aren't savvy or can't advocate for themselves have that helping hand."

Read the original report here: 
http://bit.ly/1obsza4

Source: US News



Feature
Recommended Articles
Urologists at Cancer Research UK have identified 5 distinct genomic signatures in prostate cancer that can have important implications on treatment decisions.
Fifty years ago today, President Lyndon B. Johnson signed the law that created Medicare and Medicaid, setting in motion not only the greatest change in healthcare in the nation's history at that point, but also a lasting change for society.
A quirk in Alaska law allowed Governor Bill Walker to move ahead without support from the legislature.
Patients on fluticasone propionate/salmeterol maintenance therapy who have more frequent physician interactions, especially interactions with asthma specialists, may be more likely have their controller medication reduced.
New research studies show that anti-inflammatory agents can improve survival as well as quality of life in cancer patients.